Study to Evaluate ASN002 in Subjects With Moderate To Severe Chronic Hand Eczema

Status:
Completed

Trial end date:
2020-04-28

Target enrollment:

Participant gender:

Randomized double-blind/placebo study to evaluate the efficacy of ASN002 in subjects with severe chronic hand eczema.

Phase 2

Asana BioSciences